Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 211 of the 215 references it cites were found in a registry or an index.

Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications

Open access
Jin, Wook · 2020 · Cancers

Abstract

Src family kinases (SFKs) are non-receptor kinases that play a critical role in the pathogenesis of colorectal cancer (CRC). The expression and activity of SFKs are upregulated in patients with CRC. Activation of SFKs promotes CRC cell proliferation, metastases to other organs and chemoresistance, as well as the formation of cancer stem cells (CSCs). The enhanced expression level of Src is associated with decreased survival in patients with CRC. Src-mediated regulation of CRC progression involves various membrane receptors, modulators, and suppressors, which regulate Src activation and its downstream targets through various mechanisms. This review provides an overview of the current understanding of the correlations between Src and CRC progression, with a special focus on cancer cell proliferation, invasion, metastasis and chemoresistance, and formation of CSCs. Additionally, this review discusses preclinical and clinical strategies to improve the therapeutic efficacy of drugs targeting Src for treating patients with CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers12051339

Cites

211 of 211 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Receptor-mediated signaling pathways that activate Src during the progression of colorectal cancer (CRC). Several receptor-mediated signaling pathways activate Src, which plays an essential role in the progression of CRC. Src is activated by the ligand/receptor signaling complexes, including EGF/EGFR, HGF/c-MET, VEGF/VEGFR, FGFR, IL4/IL-13Rα2, and IL6/IL-11 signaling pathways, which further activate their downstream target signaling pathways, such as the AKT/NF-κB/HO-1, MAPK/ERK, and other oncoproteins to enhance proliferation, vascularization, and metastasis of CRC cells. Further, several G-coupled protein receptors (GPCRs) are involved in CRC progression through the activation of Src-mediated signaling pathways. PGE2/EP1, PARs, and CCK2R enhance cell proliferation by activating the EGFR/Src/MAPK/ERK and HIF-1α/Src/AKT/VEGF signaling axis. Additionally, the activation of Wnt-β-catenin signaling by Src-induced Rac1, which enhances reactive oxygen species (ROS) generation, results in enhanced migration of CRC cells.
Figure 1 Receptor-mediated signaling pathways that activate Src during the progression of colorectal cancer (CRC). Several receptor-mediated signaling pathways activate Src, which plays an essential role in the progression of CRC. Src is activated by the ligand/receptor signaling complexes, including EGF/EGFR, HGF/c-MET, VEGF/VEGFR, FGFR, IL4/IL-13Rα2, and IL6/IL-11 signaling pathways, which further activate their downstream target signaling pathways, such as the AKT/NF-κB/HO-1, MAPK/ERK, and other oncoproteins to enhance proliferation, vascularization, and metastasis of CRC cells. Further, several G-coupled protein receptors (GPCRs) are involved in CRC progression through the activation of Src-mediated signaling pathways. PGE2/EP1, PARs, and CCK2R enhance cell proliferation by activating the EGFR/Src/MAPK/ERK and HIF-1α/Src/AKT/VEGF signaling axis. Additionally, the activation of Wnt-β-catenin signaling by Src-induced Rac1, which enhances reactive oxygen species (ROS) generation, results in enhanced migration of CRC cells.CC BY · PubMed Central
Figure 2 Modulators and suppressors were regulating Src activation during the progression of colorectal cancer (CRC). (A) Several cellular components positively promote the progression of CRC through Src activation. The expression levels of aryl hydrocarbon receptor (AhR), receptor-type protein tyrosine phosphatase (PTPR; PTP1B, RPTPα, and PRL-3), MetAP2, Neu, HSP90, DGKα and CD155 are upregulated in patients with CRC. These components activate Src and its downstream target signaling to enhance survival, invasion and chemoresistance of CRC cells. (B) Cell proliferation and metastasis of CRC cells are inhibited by inhibiting the activation of Src by multiple intracellular regulators, including C-terminal Src Kinase (CSK), protein tyrosine phosphatases (PTPRs), protein tyrosine phosphatase receptor type O (PTPRO), protein tyrosine phosphatase receptor type T (PTPRT), microRNAs (miRNAs), CSK-homologous kinase (CHK), downstream of tyrosine kinase-4 (Dok-4), reversion-induced LIM (Lin-1, Isl1, Mec3) (RIL), Receptor for activated C kinase 1 (RACK1), and RUNX family transcription factor 3 (RUNX3).
Figure 2 Modulators and suppressors were regulating Src activation during the progression of colorectal cancer (CRC). (A) Several cellular components positively promote the progression of CRC through Src activation. The expression levels of aryl hydrocarbon receptor (AhR), receptor-type protein tyrosine phosphatase (PTPR; PTP1B, RPTPα, and PRL-3), MetAP2, Neu, HSP90, DGKα and CD155 are upregulated in patients with CRC. These components activate Src and its downstream target signaling to enhance survival, invasion and chemoresistance of CRC cells. (B) Cell proliferation and metastasis of CRC cells are inhibited by inhibiting the activation of Src by multiple intracellular regulators, including C-terminal Src Kinase (CSK), protein tyrosine phosphatases (PTPRs), protein tyrosine phosphatase receptor type O (PTPRO), protein tyrosine phosphatase receptor type T (PTPRT), microRNAs (miRNAs), CSK-homologous kinase (CHK), downstream of tyrosine kinase-4 (Dok-4), reversion-induced LIM (Lin-1, Isl1, Mec3) (RIL), Receptor for activated C kinase 1 (RACK1), and RUNX family transcription factor 3 (RUNX3).CC BY · PubMed Central
Figure 3 Src activation enhances aggressiveness, chemoresistance and acquisition of cancer stem cell (CSC) properties of colorectal cancer (CRC) by inducing epithelial-to-mesenchymal transition (EMT). Src family kinase (SFK) (A) and several cellular processes, such as Src activator (B)-mediated activation of AKT, MAPK/ERK and FAK, promote EMT by downregulating E-cadherin and inducing β-catenin-dependent malignant processes and N-cadherin expression, through induction of EMT-associated transcriptional factors, such as Twist-1, Snail and Zab1. (C) SOCS-1 inhibits EMT through the induction of NRF2 and Trx1 by inhibiting Src. Additionally, CLDN7-mediated inhibition of CLDN1 and SASH1-mediated inhibition of CRKL suppress Src activation and inhibit EMT.
Figure 3 Src activation enhances aggressiveness, chemoresistance and acquisition of cancer stem cell (CSC) properties of colorectal cancer (CRC) by inducing epithelial-to-mesenchymal transition (EMT). Src family kinase (SFK) (A) and several cellular processes, such as Src activator (B)-mediated activation of AKT, MAPK/ERK and FAK, promote EMT by downregulating E-cadherin and inducing β-catenin-dependent malignant processes and N-cadherin expression, through induction of EMT-associated transcriptional factors, such as Twist-1, Snail and Zab1. (C) SOCS-1 inhibits EMT through the induction of NRF2 and Trx1 by inhibiting Src. Additionally, CLDN7-mediated inhibition of CLDN1 and SASH1-mediated inhibition of CRKL suppress Src activation and inhibit EMT.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 215 references

Research works printed but not linked: 1

  1. Schoenherr, 2014, Eps8 controls Src- and FAK-dependent phenotypes in squamous carcinoma cells, J. Cell Sci., 127, 5303

Cited by

See all 86

Metadata

Authors
Jin, W.
Affiliations
Gachon University (KR)
Corresponding author
Jin, Wook
Venue
Cancers
Publisher
MDPI AG
Published
2020-05-23
Volume
12
Issue
5
Pages
1339
ISSN
2072-6694 (ISSN-L)
OpenAlex
W3026270876
Cited by
86
References
215
Citations by year
2026: 9 · 2025: 10 · 2024: 13 · 2023: 20 · 2022: 16 · 2021: 11 · 2020: 6
FWCI
2.03
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Research Foundation of Korea (2020R1A2C1012484)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
Src family kinases, colorectal cancer, tumor progression, cell proliferation, metastasis, chemoresistance, cancer stem cells, Src kinase inhibitor, non-receptor tyrosine kinase, patient survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications. https://app.cochat.ai/papers/10.3390/cancers12051339
The paper
Jin, W. (2020). Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications. Cancers. https://doi.org/10.3390/cancers12051339

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.